1. Home
  2. EDAP

as of 12-04-2025 9:30am EST

$2.35
$0.06
-2.70%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Chart Type:
Time Range:
Founded: 1979 Country:
France
France
Employees: N/A City: N/A
Market Cap: 75.5M IPO Year: 1997
Target Price: $8.50 AVG Volume (30 days): 41.0K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.61 EPS Growth: N/A
52 Week Low/High: $1.21 - $3.05 Next Earning Date: 11-06-2025
Revenue: $74,853,925 Revenue Growth: 0.61%
Revenue Growth (this year): -3.8% Revenue Growth (next year): 2.67%

AI-Powered EDAP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 81.48%
81.48%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest EDAP TMS S.A. News

EDAP Breaking Stock News: Dive into EDAP Ticker-Specific Updates for Smart Investing

All EDAP News

Share on Social Networks: